News

June 5, 2017

Noninvasive Deep Brain Stimulation Can Become Reality, Mouse Study Shows

News

Researchers have, for the first time, showed that it is possible to stimulate structures deep within the brain without the need for implanted electrodes — opening the possibility that epilepsy patients could ... Read more

June 2, 2017

Three Epilepsy-device Inventors Share $200,000 in Shark Tank Competition

News

A portable electroencephalogram recorder, a sound-based seizure detection system, and a device that can predict seizures have won the Epilepsy Foundation’s Shark Tank Competition for epilepsy innovations. The winners will share $200,000 that ... Read more

May 31, 2017

Special Magazine Issue Focuses on Cannabis and Cannabinoids Use for Epilepsy Disorders

News

In the past few years the scientific community has been addressing the potential benefits of cannabinoids — compounds extracted from the cannabis plant — to treat several medical conditions, including ... Read more

May 26, 2017May 26, 2017

Modified-Release Lacosamide, ADS-4101, Seen as Safe and Well-Tolerated in Phase 1 Study

News

Results of an early clinical trial found that a partial-onset seizure treatment, ADS-4101 (modified-release lacosamide) tablets, are safe and well-tolerated when compared to Vimpat, an approved but immediate-release version of the medication, ... Read more

May 24, 2017

Herantis Granted US Patent for Therapeutic Use of MANF for Epilepsy, Other Neurological Diseases

News

Herantis Pharma was granted a patent by the U.S. Patent and Trademark Office (USPTO) for the use of MANF (mesencephalic astrocyte-derived neurotrophic factor) in the treatment of neurological diseases like epilepsy, ... Read more

May 22, 2017May 22, 2017

Epilepsy Seizure Treatment Trobalt to Be Discontinued in June 2017

News

GlaxoSmithkline (GSK) announced that its epilepsy seizure drug Trobalt (retigabine) will no longer be commercially available after June 2017. The company has advised healthcare providers to seek alternative medicines for ... Read more

May 19, 2017May 19, 2017

Possible Link Between Type of Brain Cells and Absence Epilepsy Is Subject of Study

News

A grant from Epilepsy Research UK will allow researchers to study a specific type of brain cells in hopes of identifying a new therapeutic target to treat absence epilepsy, a form of the ... Read more

May 17, 2017

Protein Found That May Improve Epilepsy Patients’ Response to Therapies

News

A protein that may help epilepsy patients respond better to drug therapies has been identified, a new study suggests. The study, titled “Molecular isoforms of high-mobility group box 1 are ... Read more

May 15, 2017May 15, 2017

Stem Cell Therapy Shows Potential in Treating Medication-resistant Epilepsy Patients

News

Stem cell therapy may be a safe and promising treatment option for epilepsy patients who are resistant to antiepileptic drugs, according to new research. The study, “Treatment of refractory epilepsy ... Read more

May 12, 2017

Stimulation of Brain Regulatory System Improves Seizures, Guinea Pig Study Shows

News

Stimulation of the endocannabinoid system — a natural regulator in the brain that modulates the release of agents that excite or inhibit central nervous system activity — prompts beneficial changes ... Read more